Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.769 USD | +2.53% | +2.10% | +4.63% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.63% | 20.26M | |
+3.62% | 99.85B | |
+1.61% | 29.64B | |
+7.95% | 21.46B | |
-8.79% | 19.15B | |
-7.09% | 17.59B | |
+1.18% | 13.96B | |
-6.34% | 11.64B | |
-2.10% | 10.26B | |
-9.35% | 9B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Sector Update: Energy